Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Partnership between NICE and Health Technology Wales established

17 Mar 2020

The National Institute for Health and Care Excellence (NICE) and Health Technology Wales (HTW) have formally committed to work together to enhance their independent and authoritative Guidance on non-medicine technologies. On March 3, 2020, it was announced about the collaboration of these two organizations.

The organizations have signed a Memorandum of Understanding, which outlines their collaboration in the strategic planning and delivery of independent and authoritative medical technology guidance in England and Wales.

National Institute for Health and Care Excellence and Health Technology Wales conduct health technology assessments on medical device innovations to determine their safety, clinical, and cost-effectiveness. The agreement of the collaboration will increase co-operation between assessors in England and Wales.

See the full details here.

HTW had also signed a memorandum with Irish and Scottish HTA bodies last year.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.